Efficacy and safety of agomelatine in patients with major depressive disorder compared to escitalopram: a randomized, double-blind study

被引：0
|
作者：
Quera-Salva, M. -A. [1 ]
Hajak, G. [2 ]
Keufer-Le Gall, S. [3 ]
Nutt, D. [4 ]
机构：
[1] Hop Raymond Poincare, Garches, France
[2] Univ Regensburg, D-8400 Regensburg, Germany
[3] IRIS, Courbevoie, France
[4] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2010年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [1] A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder
    Komaram, Ravi Babu
    Nukala, Srikrishna
    Palla, Jayasree
    Nambaru, Lakshmana Rao
    Kasturi, Satyanarayana Murthy
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (06) : VC5 - VC8
  • [2] The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study
    Wang, Xiaoliang
    Fan, Yimin
    Li, Guanjun
    Li, Huafang
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 133 - 139
  • [3] Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Zajecka, John
    Schatzberg, Alan
    Stahl, Stephen
    Shah, Amy
    Caputo, Angelika
    Post, Anke
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 135 - 144
  • [4] Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial
    Corruble, Emmanuelle
    de Bodinat, Christian
    Belaidi, Carole
    Goodwin, Guy M.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (10): : 2219 - 2234
  • [5] Efficacy and tolerability of reboxetine compared with citalopram -: A double-blind study in patients with major depressive disorder
    Langworth, S
    Bodlund, O
    Ågren, H
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (02) : 121 - 127
  • [6] Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder
    Moore, N
    Verdoux, H
    Fantino, B
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (03) : 131 - 137
  • [7] Superior antidepressant efficacy of agomelatine vs fluoxetine in severe major depressive disorder patients: a randomised, double-blind study
    Hale, A.
    Corral, R.
    Mencacci, O.
    Saiz Ruiz, J.
    Severo, C. Albarran
    Gentil, V.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S418 - S419
  • [8] Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial
    Yu, Yi-Min
    Gao, Ke-Run
    Yu, Hao
    Shen, Yi-Feng
    Li, Hua-Fang
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (03) : 226 - 233
  • [9] Efficacy of agomelatine in elderly patients with major depressive disorder (MDD). Arandomised, double-blind study vs. placebo
    Heun, R.
    Corral, R. M.
    Ahokas, A.
    Nicolini, H.
    Teixeira, J. M.
    Dehelean, P.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 147 - 148
  • [10] A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder
    Brown, E. Sherwood
    Sayed, Nasreen
    Van Enkevort, Erin
    Kulikova, Alexandra
    Nakamura, Alyson
    Khan, David A.
    Ivleva, Elena I.
    Sunderajan, Prabha
    Bender, Bruce G.
    Holmes, Traci
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (05): : 1604 - 1612
12345